Slim Weight Loss Clinic（Jacksonville, FL）
常见问题
How long before Semaglutide starts to work?
Patients who use Semaglutide for weight loss typically begin seeing results after the first four weeks of treatment.
Is Semaglutide approved for weight loss?
Yes, Semaglutide is FDA approved as a safe and effective treatment for weight management and obesity.
What is the difference between Saxenda and Semaglutide?
Although both Saxenda (Liraglutide) and Semaglutide are GLP-1 agonists that mimic the glucagon-like peptide, Semaglutide is more effective at improving blood glucose levels and achieving weight loss than Saxenda. In terms of convenience, Semaglutide is also more tolerable as a once-a-week injection, whereas Saxenda injections require daily injections.
What if I miss a dose?
If you miss administering a dose of Semaglutide, you should take it as soon as you remember. If the time frame is too close to your next dose, you should skip the missed dose altogether and resume your normal dosing schedule to avoid double dosing.
Can the drug improve overall health?
Yes. By improving weight loss, Semaglutide can also help improve cardiovascular, physical, and mental health, which leads to improved overall health.
How long does it take to lose weight on Semaglutide?
That will depend on your body type and the level of treatment. However, patients using semaglutide typically start noticing results after a few weeks of treatment.
How do I know if I am eligible for these weight loss medications?
Eligibility for weight loss medications depends on factors such as your BMI, medical history, and the presence of weight-related health conditions. A consultation with a healthcare provider will determine the best treatment plan for you.
What lifestyle changes should accompany these medications for best results?
For optimal results, these medications should be used in conjunction with a healthy diet, regular physical activity, and behavioral changes. These lifestyle adjustments help sustain weight loss and improve overall health.
How long will I need to take these medications?
The duration of treatment varies based on individual goals and response to the medication. Some patients may need to continue the medication long-term to maintain weight loss and manage appetite.
Are there any common side effects associated with these medications?
Common side effects of GLP-1 receptor agonists (like Semaglutide and Liraglutide and Tirzepatide) include nausea, vomiting, diarrhea, and constipation. These side effects often decrease over time as your body adjusts to the medication.
Can I use Metformin in combination with other weight loss medications?
Metformin may be safely combined with other weight loss medications such as GLP-1 receptor agonists. Your doctor will create a tailored plan that may include metformin based on your health needs to maximize the effectiveness of your weight loss regimen.
What are the benefits of using Metformin for weight loss?
Metformin is primarily used to treat type 2 diabetes but has been found to aid in weight loss by improving insulin sensitivity and reducing appetite. It is often prescribed as part of a weight loss program, especially for individuals with insulin resistance.
How does Tirzepatide work for weight loss?
Tirzepatide is a dual GLP-1 and GIP receptor agonist. It mimics hormones involved in appetite regulation and glucose metabolism, leading to substantial weight loss when combined with a healthy diet and exercise.
What is Semaglutide and how does it help with weight loss?
Semaglutide is a GLP-1 receptor agonist that may help regulate appetite and food intake. It is administered as a weekly injection and may assist with significant weight loss.
诊所简介
Slim Weight Loss Clinic in Jacksonville, FL offers telehealth GLP-1 therapy with semaglutide, tirzepatide, and liraglutide for chronic weight management.
Slim Weight Loss Clinic operates as a telehealth-focused weight management practice serving patients throughout Jacksonville, FL and surrounding regions. Under the direction of a board-certified physician holding MD and FACS credentials, the clinic specializes in medically supervised weight loss programs that integrate prescription GLP-1 receptor agonist therapies with individualized metabolic assessments. The practice addresses chronic weight management challenges through evidence-based pharmacotherapy protocols designed for patients who have not achieved sustainable results through diet and exercise modifications alone.
The clinic’s treatment portfolio centers on three FDA-approved GLP-1 medications: liraglutide, semaglutide, and tirzepatide. Liraglutide therapy typically begins at lower doses with gradual titration based on patient tolerance and response metrics. Semaglutide protocols follow weekly injection schedules with dosage adjustments determined by weight loss velocity and glycemic control parameters in patients with concurrent type 2 diabetes. Tirzepatide represents the clinic’s dual GIP/GLP-1 receptor agonist option, prescribed for patients requiring enhanced metabolic intervention or those who have demonstrated suboptimal response to single-agonist therapies. Each medication selection follows comprehensive metabolic panel review, cardiovascular risk stratification, and assessment of contraindications including personal or family history of medullary thyroid carcinoma.
The lead physician’s FACS certification indicates advanced surgical training, providing a depth of understanding regarding obesity as a complex metabolic disease rather than simply a lifestyle issue. This surgical background informs the clinic’s approach to patient selection for pharmacotherapy versus potential surgical intervention discussions. Initial consultations include detailed medical history review focusing on previous weight loss attempts, comorbid conditions such as hypertension or dyslipidemia, current medication regimens, and realistic goal-setting discussions. The clinic does not promise specific weight loss percentages but instead establishes individualized benchmarks based on starting BMI, metabolic health markers, and patient-specific factors.
Patients engage with Slim Weight Loss Clinic entirely through telehealth platforms, eliminating geographic barriers for Jacksonville-area residents and those in surrounding Florida communities. Virtual consultations include video assessments where providers review lab work, discuss medication side effect profiles including nausea and gastrointestinal adjustments common during GLP-1 initiation, and establish monitoring protocols. Follow-up appointments occur at intervals determined by medication type and patient stability, typically ranging from bi-weekly during titration phases to monthly once therapeutic doses are established. The clinic requires patients to obtain baseline and periodic laboratory studies through local facilities, with results reviewed before prescription adjustments.
Slim Weight Loss Clinic partners with specialized compounding and commercial pharmacies to facilitate medication access and insurance navigation. This pharmacy collaboration addresses prior authorization requirements, provides cost transparency for self-pay patients, and ensures consistent medication supply chains. The practice treats obesity as a chronic disease requiring ongoing management rather than a short-term intervention, with protocols designed for extended treatment durations consistent with current medical guidelines for GLP-1 therapy. Patients receive education on realistic expectations, the role of continued lifestyle modifications alongside pharmacotherapy, and strategies for maintaining metabolic improvements achieved during active treatment phases.